Profile data is unavailable for this security.
About the company
Gaush Meditech Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of ophthalmic medical devices and consumables. The Company operates through four segments. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently. The Distribution Products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by other ophthalmic medical equipment manufacturers. The Technical Services segment provides warranty services, maintenance services and consumables used in after-sales services. The Other segment primarily include the licensing out of intellectual properties, as well as providing services related to Clinical Research Organization (CRO).
- Revenue in HKD (TTM)1.64bn
- Net income in HKD115.79m
- Incorporated1998
- Employees819.00
- LocationGaush Meditech LtdRoom 1901, Building AZhonghui Plaza, No.11 Dongzhimen South ABEIJING ChinaCHN
- Websitehttps://www.gaush.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ClouDr Group Ltd | 2.56bn | -1.08bn | 477.83m | 966.00 | -- | 0.4369 | -- | 0.1864 | -1.82 | -1.82 | 4.34 | 1.69 | 0.8655 | 2.95 | 3.46 | 2,104,725.00 | -38.96 | -79.82 | -70.33 | -- | 33.50 | 26.37 | -45.01 | -74.91 | 0.9896 | -60.82 | 0.2871 | -- | -5.49 | 46.08 | -59.85 | -- | 78.43 | -- |
| Vincent Medical Holdings Ltd | 869.70m | 87.51m | 652.67m | 1.46k | 7.28 | 1.04 | 5.04 | 0.7505 | 0.136 | 0.136 | 1.35 | 0.9542 | 0.9226 | 3.30 | 3.96 | 654,893.10 | 9.72 | 10.32 | 13.97 | 14.95 | 34.47 | 34.77 | 10.53 | 10.25 | 1.55 | -- | 0.2049 | 37.10 | 11.56 | 9.79 | 20.76 | 43.10 | 26.32 | 24.57 |
| Broncus Holding Corp | 47.54m | -118.50m | 785.35m | 193.00 | -- | 0.6253 | -- | 16.52 | -0.2443 | -0.2443 | 0.098 | 2.38 | 0.0347 | 0.4314 | 0.855 | 237,716.30 | -8.65 | -44.03 | -8.96 | -46.77 | 72.36 | 76.11 | -249.25 | -849.59 | 26.33 | -- | 0.0003 | -- | -20.71 | 0.1458 | 45.52 | -- | -2.79 | -- |
| BioSino Bio-technology and Science Inc | 255.76m | -53.78m | 790.10m | 471.00 | -- | 4.64 | -- | 3.09 | -0.3717 | -0.3717 | 1.77 | 1.18 | 0.4633 | 2.41 | 1.59 | 512,537.70 | -12.66 | -2.01 | -33.54 | -5.46 | 38.77 | 39.79 | -27.32 | -3.72 | 0.7174 | -5.03 | 0.477 | -- | -9.00 | -7.92 | -265.14 | -- | -3.59 | -- |
| China Health Group Ltd | 39.87m | -60.77m | 887.77m | 127.00 | -- | -- | -- | 22.26 | -0.0992 | -0.0992 | 0.065 | -0.029 | 0.2052 | 2.02 | 1.76 | 269,412.20 | -31.41 | -16.08 | -261.02 | -42.30 | 22.79 | 28.29 | -153.08 | -44.72 | 0.7455 | -22.53 | -- | -- | -35.02 | -2.92 | -68.69 | -- | 30.06 | -- |
| Gaush Meditech Ltd | 1.64bn | 115.79m | 903.59m | 819.00 | 7.76 | 0.4697 | 4.35 | 0.5524 | 0.7875 | 0.7875 | 11.14 | 13.01 | 0.535 | 2.08 | 9.05 | 1,850,454.00 | 3.62 | -1.53 | 4.67 | -2.20 | 47.29 | 47.66 | 6.77 | -2.90 | 1.57 | 8.16 | 0.2188 | -- | 1.58 | 5.24 | -46.75 | -- | 79.78 | -- |
| Kaisa Health Group Holdings Ltd | 166.42m | -31.22m | 1.01bn | 917.00 | -- | 2.31 | -- | 6.06 | -0.0062 | -0.0062 | 0.033 | 0.0865 | 0.308 | 6.69 | 1.52 | 193,284.50 | -6.59 | -7.25 | -7.83 | -9.34 | 41.58 | 45.27 | -21.40 | -28.20 | 3.89 | -- | 0.0257 | -- | -0.2824 | -5.93 | -720.72 | -- | -19.69 | -- |
| Venus MedTech HangZhou Inc | 485.53m | -730.25m | 1.06bn | 605.00 | -- | 0.4526 | -- | 2.19 | -1.67 | -1.67 | 1.11 | 5.32 | 0.1218 | 0.9065 | 2.08 | 702,651.20 | -18.34 | -13.83 | -21.01 | -15.57 | 75.83 | 78.74 | -150.57 | -151.55 | 1.56 | -32.63 | 0.1928 | -- | -4.18 | 15.08 | -1.50 | -- | 11.12 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 23.71m | -101.51m | 1.16bn | 70.00 | -- | 2.14 | -- | 48.87 | -0.417 | -0.417 | 0.0974 | 2.23 | 0.0251 | 0.8435 | 3.43 | 376,314.70 | -11.04 | -30.86 | -12.96 | -32.99 | 46.47 | -- | -439.71 | -- | 11.95 | -1.47 | 0.203 | -- | -- | -- | 50.00 | -- | 25.75 | -- |
| Beijing Airdoc Technology Co Ltd | 166.34m | -200.72m | 1.17bn | 193.00 | -- | 0.8208 | -- | 7.06 | -1.96 | -1.96 | 1.63 | 13.96 | 0.1002 | 1.57 | 2.80 | 589,846.10 | -12.54 | -12.40 | -13.31 | -13.54 | 66.29 | 56.72 | -125.12 | -128.07 | 8.71 | -- | 0.0098 | -- | -23.34 | 38.74 | -92.75 | -- | 1.28 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 276.00k | 0.19% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 29.31k | 0.02% |
| DFA Australia Ltd.as of 30 Nov 2025 | 1.29k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
